Trials / Completed
CompletedNCT02569853
DFN-11 Injection in Episodic Migraine With or Without Aura
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 268 (actual)
- Sponsor
- Dr. Reddy's Laboratories Limited · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Safety and Efficacy of DFN-11 in patients with episodic migraines with or without aura.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DFN-11 | |
| OTHER | Placebo |
Timeline
- Start date
- 2015-09-21
- Primary completion
- 2017-05-30
- Completion
- 2018-02-26
- First posted
- 2015-10-07
- Last updated
- 2018-07-26
- Results posted
- 2018-07-26
Locations
16 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02569853. Inclusion in this directory is not an endorsement.